Dealmaking in the pharmaceuticals and healthcare sector saw a rebound in H1 2017, with deal value increasing 51.8 percent compared to the preceding half-year. The sector delivered 244 deals worth US$98.2 billion during the period, making it the third-largest industry by deal value and fourth-largest by deal volume.